19920405
 Letters to the Editor: This Time, the FDA Made Right Decision   The Wall Street Journal,  Apr 6, 1992  Your Feb. 24 editorial "FDA Does and Doesn't" provides ample criticism of "regulatory chaos" at the FDA surrounding breast implants. The handling of the breast-implant controversy may indeed be worthy of criticism, but your brief mention of "a small company called Therakos Inc." and its application with the FDA for approval of photopheresis as a treatment for scleroderma was misleading and inappropriate in the context of your editorial.   
